{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:40:36Z","timestamp":1792597236741,"version":"4.5.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pertussis is a highly contagious disease caused by <jats:italic>Bordetella pertussis<\/jats:italic> (BP) and remains endemic worldwide, with cyclic epidemics occurring every 2\u20135\u202fyears. Non-pharmaceutical interventions (NPIs) implemented during the COVID-19 have altered the epidemiology of respiratory infectious diseases. Pertussis have increased sharply since mid-late 2023, showing a nationwide epidemic. Understanding the epidemiological shifts is crucial for effective prevention. This study analyzed the prevalence and epidemiological characteristics of pertussis among children with respiratory infections from 2022 to 2024.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed BP-positive cases identified by targeted sequencing for multiple respiratory pathogens in children aged 0\u201318\u202fyears with respiratory infections treated at our hospital from January 2022 to December 2024. Demographic characteristics, positivity rates, age distribution, and co-infecting pathogens were retrospectively assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 20,059 samples were included, with an overall BP positivity rate of 9.83%. The A2047G macrolide resistance mutation rate was significantly increased from 0.24% in 2022 to 6% in 2023 and 42.86% in 2024, respectively (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u202f=\u202f500.22, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). Annual BP positivity rates showed a significant increase from 2022 to 2024 (14.56, 3.26, and 32.24%, respectively; <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u202f=\u202f2698.353, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). Peak detection periods were July to October in 2022, extended from July through December in 2023, and persisted from January to October in 2024. The proportion of BP-positive cases aged &amp;gt;3\u20136\u202fyears and 6\u201318\u202fyears showed increasing trends (<jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub> &amp;lt; 0.01 and <jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub> &amp;lt; 0.001, respectively). BP co-detection rates with specific pathogens\u2014human rhinovirus, adenovirus, <jats:italic>Haemophilus influenzae<\/jats:italic>, <jats:italic>Staphylococcus aureus<\/jats:italic>, and <jats:italic>Mycoplasma pneumoniae<\/jats:italic> significantly increased (all <jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub> &amp;lt; 0.05), whereas parainfluenza virus co-infections decreased (<jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub> &amp;lt; 0.05). No significant change occurred in <jats:italic>Streptococcus pneumoniae<\/jats:italic> co-infections (<jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub> &amp;gt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study reveals significant shifts in pediatric pertussis epidemiology during the post-pandemic era, characterized by rising incidence, non-seasonal surges, increased school-aged cases, and heightened co-detection rates. These findings call for enhanced drug-resistant BP surveillance, strengthened vaccination (especially among school-aged children in close contact with infants), improved clinical recognition, and targeted public health interventions to disrupt transmission.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1657953","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T05:35:25Z","timestamp":1756791325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular epidemiological characteristics of pertussis in a pediatric hospital in Jinan City, China, 2022 to 2024"],"prefix":"10.3389","volume":"13","author":[{"given":"Miao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1093\/infdis\/jiaa469","article-title":"Pertussis (whooping cough)","volume":"224","author":"Decker","year":"2021","journal-title":"Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/21645515.2020.1791617","article-title":"Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital","volume":"17","author":"Di Camillo","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00000441-195109000-00011","article-title":"Whooping cough and its epidemiological anomalies","volume":"222","author":"Gordon","year":"1951","journal-title":"Am J Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/132.6.707","article-title":"Can whooping cough be eradicated?","volume":"132","author":"Kendrick","year":"1975","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198811879.001.0001","volume-title":"Pertussis: Epidemiology, immunology, and evolution","author":"Rohani","year":"2018"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3969\/j.issn.1006-916X.2005.04.008","article-title":"Analysis on pertussis epidemiology in Zhejiang Province in 1954-2004","volume":"11","author":"Jian","year":"2005","journal-title":"Chin J Vaccines Immun."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.19914\/j.CJVI.2022119","article-title":"Epidemiology of pertussis in China, 2018-2021","volume":"28","author":"Dan","year":"2022","journal-title":"Chin J Vaccines Immun"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4049\/jimmunol.2000676","article-title":"Overcoming waning immunity in pertussis vaccines: workshop of the National Institute of Allergy and Infectious Diseases","volume":"205","author":"Damron","year":"2020","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0138941","DOI":"10.1371\/journal.pone.0138941","article-title":"Variation in Bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970-2014)","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"O825","DOI":"10.1111\/1469-0691.12671","article-title":"High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","article-title":"Pertussis vaccines, epidemiology and evolution","volume":"22","author":"Domenech de Cell\u00e8s","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.pulmoe.2024.04.009","article-title":"Unraveling the resurgence of pertussis: insights into epidemiology and global health strategies","volume":"30","author":"Wan","year":"2024","journal-title":"Pulmonology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1212658","DOI":"10.3389\/fped.2023.1212658","article-title":"Epidemiological characteristics of common respiratory infectious diseases in children before and during the COVID-19 epidemic","volume":"11","author":"Wang","year":"2023","journal-title":"Front Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"107672","DOI":"10.1016\/j.biotechadv.2020.107672","article-title":"CRISPR-based enrichment strategies for targeted sequencing","volume":"46","author":"Schultzhaus","year":"2021","journal-title":"Biotechnol Adv"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"659164","DOI":"10.3389\/fped.2021.659164","article-title":"Etiology of severe pneumonia in children in alveolar lavage fluid using a high-throughput gene targeted amplicon sequencing assay","volume":"9","author":"Li","year":"2021","journal-title":"Front Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3969\/j.issn.1009-6663.2025.04.009","article-title":"Comparative study on the clinical characteristics and laboratory detection methods of pertussis cases of multicenter pertussis cases in Hebei province","volume":"30","author":"Huang","year":"2025","journal-title":"J Clin Pulmon Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.3760\/cma.j.cn112137-20240927-02208","article-title":"Expert consensus on the application and practice of targeted next-generation sequencing in infectious diseases","volume":"104","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"105307","DOI":"10.1016\/j.ebiom.2024.105307","article-title":"Enhancing lower respiratory tract infection diagnosis: implementation and clinical assessment of multiplex PCR-based and hybrid capture-based targeted next-generation sequencing","volume":"107","author":"Yin","year":"2024","journal-title":"EBioMedicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/S1473-3099(18)30646-7","article-title":"PERISCOPE: road towards effective control of pertussis","volume":"19","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/14760584.2020.1831916","article-title":"The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China","volume":"19","author":"Yao","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2466691","DOI":"10.1080\/22221751.2025.2466691","article-title":"As pertussis returns to pre-COVID19 endemicity, vaccination remains our best ally against an evolving Bordetella pertussis","volume":"14","author":"Mei","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1073\/pnas.1014394108","article-title":"Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure","volume":"108","author":"Lavine","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3947\/ic.2024.0117","article-title":"Pertussis in the post-COVID-19 era: resurgence, diagnosis, and management","volume":"57","author":"Kang","year":"2025","journal-title":"Infect Chemother"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3760\/cma.j.cn112137-20240124-00179","article-title":"Guidelines for diagnosis and management and prevention of pertussis of China (2024 edition)","volume":"104","year":"2024","journal-title":"Zhong Hua Yi Xue Za Zhi"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"106170","DOI":"10.1016\/j.jinf.2024.106170","article-title":"Infections in preschool and school-aged children are driving the recent rise in pertussis in China","volume":"88","author":"Hu","year":"2024","journal-title":"J Infect"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/vaccines12111261","article-title":"Resurgence of pertussis in the Gyeongnam region of South Korea in 2023 and 2024","volume":"12","author":"Lee","year":"2024","journal-title":"Vaccines"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.1194134","article-title":"Contact network structure explains the changing epidemiology of pertussis","volume":"330","author":"Rohani","year":"2010","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/archpediatrics.2011.1093","article-title":"Early impact of the US Tdap vaccination program on pertussis trends","volume":"166","author":"Skoff","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e1149","DOI":"10.1542\/peds.2013-1747","article-title":"Infant hospitalizations for pertussis before and after Tdap recommendations for adolescents","volume":"132","author":"Auger","year":"2013","journal-title":"Pediatrics"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3201\/eid2512.181836","article-title":"High prevalence of macrolide-resistant Bordetella pertussis and ptxP1 genotype, mainland China, 2014-2016","volume":"25","author":"Li","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"106336","DOI":"10.1016\/j.jinf.2024.106336","article-title":"Global pertussis resurgence: an urgent call for macrolide resistance monitoring","volume":"89","author":"Guo","year":"2024","journal-title":"J Infect"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"901617","DOI":"10.3389\/fmicb.2022.901617","article-title":"A cross-sectional study revealing the emergence of erythromycin-resistant Bordetella pertussis carrying ptxP3 alleles in China","volume":"13","author":"Wu","year":"2022","journal-title":"Front Microbiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmi.2024.08.016","article-title":"Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China","volume":"30","author":"Fu","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"eaaj1748","DOI":"10.1126\/scitranslmed.aaj1748","article-title":"The impact of past vaccination coverage and immunity on pertussis resurgence","volume":"10","author":"Domenech de Cell\u00e8s","year":"2018","journal-title":"Sci Transl Med"},{"key":"ref38","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--advisory committee on immunization practices (ACIP), 2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.19367\/j.cnki.1000-2707.2017.11.012","article-title":"Seroprevalence analysis of pertussis infection of hospitalized children with clinical diagnoses of pneumonia or asthma","volume":"42","author":"Qing","year":"2017","journal-title":"J Gui Zhou Med Univ"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3969\/j.issn.1673-5501.2016.03.008","article-title":"The cross-sectional study on the prevalence of pertussis in children with protracted cough in a single center in Jinan","volume":"11","author":"Yu","year":"2016","journal-title":"Chin J Evid Based Pediatr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.6040\/j.issn.1671-7554.0.2024.0435","article-title":"Correlation between asthma and pertussis infection in children of Shandong Province, China","volume":"62","author":"Jin","year":"2024","journal-title":"J Shandong Univ"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3889\/oamjms.2018.332","article-title":"Respiratory viruses and atypical bacteria co-infection in children with acute respiratory infection","volume":"6","author":"Baroudy","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13052-025-01865-4","article-title":"A new epidemic wave of Bordetella pertussis in paediatric population: impact and role of co-infections in pertussis disease","volume":"51","author":"Scutari","year":"2025","journal-title":"Ital J Pediatr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.rpped.2014.06.001","article-title":"Clinical, laboratorial and radiographic predictors of Bordetella pertussis infection","volume":"32","author":"Bellettini","year":"2014","journal-title":"Rev Paul Pediatr"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00431-007-0633-6","article-title":"Pertussis and respiratory syncytial virus infections","volume":"167","author":"Cosnes-Lambe","year":"2008","journal-title":"Eur J Pediatr"},{"key":"ref46","first-page":"131","article-title":"Bordetella pertussis and mixed infections","volume-title":"Minerva Pediatr","author":"Versteegh","year":"2006"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1038\/s41598-020-73462-w","article-title":"Co-detection of Bordetella pertussis and other respiratory organisms in children hospitalised with lower respiratory tract infection","volume":"10","author":"Muloiwa","year":"2020","journal-title":"Sci Rep"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13052-025-01949-1","article-title":"Co-infection in unvaccinated infants with acute pertussis in Western China (2018-2019): pathogen distribution and impact on disease severity","volume":"51","author":"Gan","year":"2025","journal-title":"Ital J Pediatr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3760\/j.issn:0254-6450.2006.05.022","article-title":"Research of Haemophilus influenzae type b in China","volume":"27","author":"Min","year":"2006","journal-title":"Chin J Epidemiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00705-023-05752-3","article-title":"Immediate and long-term changes in the epidemiology, infection spectrum, and clinical characteristics of viral and bacterial respiratory infections in Western China after the COVID-19 outbreak: a modeling study","volume":"168","author":"Shi","year":"2023","journal-title":"Arch Virol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e0290823","DOI":"10.1128\/spectrum.02908-23","article-title":"SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to mycoplasma pneumoniae and co-infecting respiratory viruses in Arkansas","volume":"12","author":"Boyanton","year":"2024","journal-title":"Microbiol Spectr"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/jmv.23222","article-title":"Single treatment with ethanol hand rub is ineffective against human rhinovirus--hand washing with soap and water removes the virus efficiently","volume":"84","author":"Savolainen-Kopra","year":"2012","journal-title":"J Med Virol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/INF.0000000000003414","article-title":"Differential impact of nonpharmaceutical interventions on the epidemiology of invasive bacterial infections in children during the coronavirus disease 2019 pandemic","volume":"41","author":"Kim","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1494166","DOI":"10.3389\/fcimb.2024.1494166","article-title":"Analysis of respiratory pathogens in pediatric acute respiratory infections in Lanzhou, Northwest China, 2019-2024","volume":"14","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1405710","DOI":"10.3389\/fmicb.2024.1405710","article-title":"Influence of non-pharmaceutical interventions on epidemiological characteristics of Mycoplasma pneumoniae infection in children during and after the COVID-19 epidemic in Ningbo, China","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Microbiol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15585\/mmwr.mm7307a3","article-title":"Notes from the field: reemergence of Mycoplasma pneumoniae infections in children and adolescents after the COVID-19 pandemic, United States, 2018-2024","volume":"73","author":"Edens","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"piae132","DOI":"10.1093\/jpids\/piae132","article-title":"Increasing number of clinically severe Mycoplasma pneumoniae infections in children after the COVID-19 pandemic: a single-center case series","volume":"14","author":"McCarthy","year":"2025","journal-title":"J Pediatr Infect Dis Soc"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1016\/S2666-5247(23)00182-9","article-title":"Mycoplasma pneumoniae: gone forever?","volume":"4","author":"Meyer Sauteur","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"106209","DOI":"10.1016\/j.jinf.2024.106209","article-title":"Evidence of immunity gap: decline in antibodies against M. pneumoniae during the COVID-19 pandemic","volume":"89","author":"Liu","year":"2024","journal-title":"J Infect"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1657953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T05:35:32Z","timestamp":1756791332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1657953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":59,"alternative-id":["10.3389\/fpubh.2025.1657953"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1657953","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"1657953"}}